Top news of the week: 09.06.2021.
Startups
Biotech venture capital still booming as venBio raises another $550M
VenBio has previously invested in a range of treatment areas and technologies, including cell and gene editing companies like Precision Bio and Artiva.
Bayer buys a biotech and its offshoot in bet on radiopharmaceuticals
The German drugmaker will add an experimental prostate cancer medicine to its pipeline through the deal, which reflects growing industry interest in the field.
Wall Street grapples with new SPAC equity contracts after regulator crackdown
Wall Street accountants and lawyers are trying to figure out new equity agreements to lure investors back to the blank-check company market after the U.S. regulator cracked down on the use ...
Will you accept this capital investment? Biotech and health startups bet on a strange new reality show for crowdfunding
A panel of judges that includes former NSYNC band member Lance Bass debate, on air, whether to invest in biotech and health startups.
Elevation files for $100M IPO to fund tumor-agnostic candidate
Elevation Oncology has filed to raise $100 million in an IPO. The money will support development of an anti-HER3 antibody that failed multiple trials at Merrimack Pharmaceuticals before ...
Q&A with Cellino CEO and Co-founder Nabiha Saklayen
She sat down for a fireside chat with Jennifer Griffin, MLSC Vice President, Industry Strategy and Investments, about her journey from PhD student to co-founding Cellino Biotech, …
CROs Shift from Hired Hands to Trusted Partners
Sponsors partner with contract research organizations to reduce expenditures, accelerate development, and cope with the complexity of new approaches.
Iksuda raises $47M to take CD19 antibody-drug conjugate into clinic
Iksuda Therapeutics has raised $47 million to take a CD19-targeted antibody-drug conjugate (ADC) into the clinic. The British biotech has ceded a big head start to CD19 ADC leader ADC ...